AI 检索
AI 阅读
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Less Bleeding by Omitting Aspirin in Non-ST-segment Elevation Acute Coronary Syndrome Patients: Rationale and Design of the LEGACY study.

Niels M R van der Sangen,I Tarik Küçük, Shabiga Sivanesan,Yolande Appelman,Jurriën M Ten Berg, Ashley Verburg,Jaouad Azzahhafi,E Karin Arkenbout,Wouter J Kikkert,Ron Pisters,J Wouter Jukema,Fatih Arslan,Arnoud van 't Hof,Mustafa Ilhan,Loes P Hoebers,René J van der Schaaf,Peter Damman,Pier Woudstra,Tim P van de Hoef,Matthijs Bax,Rutger L Anthonio,Jawed Polad,Tom Adriaenssens,Willem Dewilde,Carlo Zivelonghi,Peep Laanmets,Risko Majas,Marcel G W Dijkgraaf,Bimmer E P M Claessen,José P S Henriques

American heart journal（2023）

引用 1|浏览45
暂无评分
摘要
The LEGACY study is the first randomized study that is specifically designed to evaluate the impact of immediately omitting aspirin, and thus treating patients with P2Y-inhibitor monotherapy, as compared to DAPT for 12 months on bleeding and ischemic events within 12 months following PCI for NSTE-ACS.
更多
查看译文
关键词
acute coronary syndrome,aspirin,coronary syndrome patients,non-st-segment
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要